N-homocysteinylation induces different structural and functional consequences on acidic and basic proteins

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Sharma, Gurumayum Suraj ^a   Kumar, Tarun ^a   Singh, Laishram Rajendrakumar ^a  

^a UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PROTEIN; BASIC PROTEIN; HOMOCYSTEINE THIOLACTONE; HOMOCYSTEINE; LACTALBUMIN; LYSOZYME; PANCREATIC RIBONUCLEASE;

ARTICLE; BINDING AFFINITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; PROTEIN AGGREGATION; PROTEIN DENATURATION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN N HOMOCYSTEINYLATION; PROTEIN STRUCTURE; PROTEIN TARGETING; STRUCTURE ANALYSIS; ANALOGS AND DERIVATIVES; ANIMAL; BOVINE; CHEMISTRY; CHICKEN; CIRCULAR DICHROISM;

ANIMALS; CATTLE; CHICKENS; CIRCULAR DICHROISM; HOMOCYSTEINE; LACTALBUMIN; MURAMIDASE; PROTEIN DENATURATION; RIBONUCLEASE, PANCREATIC;

EID: 84920466641     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116386     Document Type: Article

References (59)

1. Jakubowski H (1991) Proofreading in vivo: editing of homocysteine by methionyl-tRNA synthetase in the yeast Saccharomyces cerevisiae. EMBO J 10: 593-598.
2. Jakubowski H (2002) The determination of homocysteine-thiolactone in biological samples. Anal Biochem 308: 112-119.
3. Jakubowski H (2006) Pathophysiological consequences of homocysteine excess. J Nutr 136: 1741-1749.
4. Jakubowski H (2007) The molecular basis of homocysteine thiolactone-mediated vascular disease. Clin Chem Lab Med 45: 1704-1716.
5. Pancharuniti N, Lewis CA, Sauberlich HE, Perkins LL, Go RC, et al. (1994) Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr 59: 940-948.
6. Gellekink H, den Heijer M, Heil SG, Blom HJ (2005) Genetic determinants of plasma total homocysteine. Semin Vasc Med 5: 98-109.
7. Refsum H, Ueland PM, Nygard O, Vollset SE (1998) Homocysteine and cardiovascular disease. Annu Rev Med 49: 31-62.
8. Hubmacher D, Tiedemann K, Reinhardt DP (2006) Fibrillins: from biogenesis of microfibrils to signaling functions. Curr Top Dev Biol 75: 93-123.
9. Kielty CM, Sherratt MJ, Marson A, Baldock C (2005) Fibrillin microfibrils. Adv Protein Chem 70: 405-436.
10. Perla-Kajan J, Twardowski T, Jakubowski H (2007) Mechanisms of homocysteine toxicity in humans. Amino Acids 32: 561-572.
11. Hubmacher D, Cirulis JT, Miao M, Keeley FW, Reinhardt DP (2010) Functional consequences of homocysteinylation of the elastic fiber proteins fibrillin-1 and tropoelastin. J Biol Chem 285: 1188-1198.
12. Lawrence de Koning AB, Werstuck GH, Zhou J, Austin RC (2003) Hyperhomocysteinemia and its role in the development of atherosclerosis. Clinical Biochemistry 36: 431-441.
13. Spence JD, Bang H, Chambless LE, Stampfer MJ (2005) Vitamin Intervention For Stroke Prevention trial: an efficacy analysis. Stroke 36: 2404-2409.
14. Dodds L, Fell DB, Dooley KC, Armson BA, Allen AC, et al. (2008) Effect of homocysteine concentration in early pregnancy on gestational hypertensive disorders and other pregnancy outcomes. Clin Chem 54: 326-334.
15. Mattson MP, Shea TB (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26: 137-146.
16. Obeid R, Herrmann W (2006) Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett 580: 2994-3005.
17. Seshadri S (2006) Elevated plasma homocysteine levels: risk factor or risk marker for the development of dementia and Alzheimer's disease? J Alzheimers Dis 9: 393-398.
18. Chwatko G, Jakubowski H (2005) Urinary excretion of homocysteine-thiolactone in humans. Clin Chem 51: 408-415.
19. Jakubowski H (2000) Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation. J Biol Chem 275: 3957-3962.
20. Zimny J, Sikora M, Guranowski A, Jakubowski H (2006) Protective mechanisms against homocysteine toxicity: the role of bleomycin hydrolase. J Biol Chem 281: 22485-22492.
21. Jakubowski H (1997) Metabolism of homocysteine thiolactone in human cell cultures. Possible mechanism for pathological consequences of elevated homocysteine levels. J Biol Chem 272: 1935-1942.
22. Jakubowski H (1999) Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels. FASEB J 13: 2277-2283.
23. Jakubowski H (2000) Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans. J Nutr 130: 377S-381S.
24. Jakubowski H, Zhang L, Bardeguez A, Aviv A (2000) Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis. Circ Res 87: 45-51.
25. Jakubowski H, Goldman E (1993) Synthesis of homocysteine thiolactone by methionyl-tRNA synthetase in cultured mammalian cells. FEBS Lett 317: 237-240.
26. Jakubowski H (2003) Homocysteine-thiolactone and S-nitroso-homocysteine mediate incorporation of homocysteine into protein in humans. Clin Chem Lab Med 41: 1462-1466.
27. Jakubowski H (2004) Molecular basis of homocysteine toxicity in humans. Cell Mol Life Sci 61: 470-487.
28. Jalili S, Yousefi R, Papari MM, Moosavi-Movahedi AA (2011) Effect of homocysteine thiolactone on structure and aggregation propensity of bovine pancreatic insulin. Protein J 30: 299-307.
29. Khazaei S, Yousefi R, Alavian-Mehr MM (2012) Aggregation and fibrillation of eye lens crystallins by homocysteinylation; implication in the eye pathological disorders. Protein J 31: 717-727.
30. Paoli P, Sbrana F, Tiribilli B, Caselli A, Pantera B, et al. (2010) Protein N-homocysteinylation induces the formation of toxic amyloid-like protofibrils. J Mol Biol 400: 889-907.
31. Stroylova YY, Chobert JM, Muronetz VI, Jakubowski H, Haertle T (2012) N-homocysteinylation of ovine prion protein induces amyloid-like transformation. Arch Biochem Biophys 526: 29-37.
32. Stroylova YY, Zimny J, Yousefi R, Chobert JM, Jakubowski H, et al. (2011) Aggregation and structural changes of alpha(S1)-, beta- and kappa-caseins induced by homocysteinylation. Biochim Biophys Acta 1814: 1234-1245.
33. Jakubowski H (2002) Homocysteine is a protein amino acid in humans: implications for homocysteinelinked disease. J Biol Chem 277: 30425-30428.
34. Hamaguchi K, Kurono A (1968) Structure of muramidase (lysozyme). I. The effect of guanidine hydrochloride on muramidase. J Biochem 54: 111-122.
35. Bigelow CC (1960) Difference spectra of ribonuclease and two ribonuclease derivatives. C R Trav Lab Carlsberg 31: 305-324.
36. Sugai S, Yashiro H, Nitta K (1973) Equilibrium and kinetics of the unfolding of alpha-lactalbumin by guanidine hydrochloride. Biochim Biophys Acta 328: 35-41.
37. Thorn DC, Meehan S, Sunde M, Rekas A, Gras SI, et al. (2005) Amyloid fibril formation by bovine milk kappa-casein, and its inhibition by the molecular chaperones alpahS and beta-casein. Biochemistry 44: 17027-17036.
38. Yazdanparast R, Khodarahmi R, Soori E (2005) Comparative studies of the artificial chaperoneassisted refolding of thermally denatured bovine carbonic anhydrase using different capturing ionic detergents and beta-cyclodextrin. Arch Biochem Biophys 437: 178-185.
39. Pace CN (1986) Determination and analysis of urea and guanidine hydrochloride denaturation curves. Methods Enzymol 131: 266-280.
40. Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82: 70-77.
41. Yang JT, Wu CS, Martinez HM (1986) Calculation of protein conformation from circular dichroism. Methods Enzymol 130: 208-269.
42. Maurel C, Westmoreland D (1976) Catalytic implications of electrostatic potential: The lytic activity of lysozyme as a model. J Mol Biol 102: 253-264.
43. Crook EM, Mathias AP, Rabin BR (1960) Spectrophotometric assay of bovine pancreatic ribonuclease by the use of cytidine 29:39-phosphate. Biochem J 74: 234-238.
44. Sinha A, Yadav S, Ahmad R, Ahmad F (2000) A possible origin of differences between calorimetric and equilibrium estimates of stability parameters of proteins. Biochem J 345 Pt 3: 711-717.
45. Chwatko G, Jakubowski H (2005) The determination of homocysteine-thiolactone in human plasma. Anal Biochem 337: 271-277.
46. Sikora M, Marczak L, Kubalska J, Graban A, Jakubowski H (2014) Identification of Nhomocysteinylation sites in plasma proteins. Amino Acids 46: 235-244.
47. Dudman NP, Hicks C, Lynch JF, Wilcken DE, Wang J (1991) Homocysteine thiolactone disposal by human arterial endothelial cells and serum in vitro. Arterioscler Thromb 11: 663-670.
48. Arora B, Narayanasamy A, Nirmal J, Halder N, Patnaik S, et al. (2014) Development and validation of a LC-MS/MS method for homocysteine thiolactone in plasma and evaluation of its stability in plasma samples. Journal of Chromatography B 944: 49-54.
49. Perla-Kajan J, Marczak L, Kajan L, Skowronek P, Twardowski T, et al. (2007) Modification by homocysteine thiolactone affects redox status of cytochrome C. Biochemistry 46: 6225-6231.
50. Zang T, Dai S, Chen D, Lee BW, Liu S, et al. (2009) Chemical methods for the detection of protein Nhomocysteinylation via selective reactions with aldehydes. Anal Chem 81: 9065-9071.
51. Ferretti G, Bacchetti T, Moroni C, Vignini A, Nanetti L, et al. (2004) Effect of homocysteinylation of low density lipoproteins on lipid peroxidation of human endothelial cells. J Cell Biochem 92: 351-360.
52. Khodadadi S, Riazi GH, Ahmadian S, Hoveizi E, Karima O, et al. (2012) Effect of Nhomocysteinylation on physicochemical and cytotoxic properties of amyloid beta-peptide. FEBS Lett 586: 127-131.
53. Stühlinger MC, Tsao PS, Her JH, Kimoto M, Balint RF, et al. (2001) Homocysteine Impairs the Nitric Oxide Synthase Pathway Role of Asymmetric Dimethylarginine. Circulation 104: 2569-2575.
54. Yousefi R, Jalili S, Alavi P, Moosavi-Movahedi AA (2012) The enhancing effect of homocysteine thiolactone on insulin fibrillation and cytotoxicity of insulin fibril. Int J Biol Macromol 51: 291-298.
55. Glowacki R, Jakubowski H (2004) Cross-talk between Cys34 and lysine residues in human serum albumin revealed by N-homocysteinylation. J Biol Chem 279: 10864-10871.
56. Topal G, Brunet A, Millanvoye E, Boucher J, Rendu F, et al. (2004) Homocysteine induces oxidative stress by uncoupling of NO synthase activity through reduction of tetrahydrobiopterin. Free Radic Biol Med 36: 1532-1541.
57. Hong L, Fast W (2007) Inhibition of Human Dimethylarginine Dimethylaminohydrolase-1 by S-Nitroso-Lhomocysteine and Hydrogen Peroxide: Analysis, quantification, and implications for hyperhomocysteinemia. J Bio Chem 282: 34684-34692.
58. Sontag E, Nunbhakdi-Craig V, Sontag JM, Diaz-Arrastia R, Ogris E, et al. (2007) Protein phosphatase 2A methyltransferase links homocysteine metabolism with tau and amyloid precursor protein regulation. J Neurosci 27: 2751-2759.
59. Karima O, Riazi G, Khodadadi S, Aryapour H, Khalili MA, et al. (2012) Altered tubulin assembly dynamics with N-homocysteinylated human 4R/1N tau in vitro. FEBS Lett 586: 3914-3919.